Our Dr. Sattva Neelapu is on the cusp of extending the reach of CAR T cell therapy to treat certain subtypes of T cell lymphoma or even some autoimmune disorders. Read more about his research. #OncSky #EndCancer
Cell therapy clinical trial could bring hope for patients with T-cell lymphoma and beyondThrough clinical trials, Sattva Neelapu, M.D., is on the cusp of extending the reach of CAR T cell therapy, a treatment that, if successful, could be used to treat certain subtypes of T cell lymphomas or even some autoimmune disorders.spr.ly